|
IKBKAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75860437323649E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.09423622677241E-12 |
| Normal-vs-Stage2 |
2.282700E-03 |
| Normal-vs-Stage3 |
1.34750000047035E-07 |
| Normal-vs-Stage4 |
2.395000E-03 |
| Stage1-vs-Stage2 |
5.982800E-01 |
| Stage1-vs-Stage3 |
4.808600E-01 |
| Stage1-vs-Stage4 |
7.267200E-01 |
| Stage2-vs-Stage3 |
3.362200E-01 |
| Stage2-vs-Stage4 |
5.405200E-01 |
| Stage3-vs-Stage4 |
9.173000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.90809623446376E-11 |
| Normal-vs-AfricanAmerican |
1.79100000385901E-08 |
| Normal-vs-Asian |
1.64908999999991E-05 |
| Caucasian-vs-AfricanAmerican |
7.569400E-01 |
| Caucasian-vs-Asian |
5.205200E-01 |
| AfricanAmerican-vs-Asian |
5.670800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85296222809939E-13 |
| Normal-vs-Female |
2.842500E-03 |
| Male-vs-Female |
1.344620E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.66400000001232E-07 |
| Normal-vs-Extreme_Weight |
4.09006162271908E-13 |
| Normal-vs-Obese |
5.91869999999606E-05 |
| Normal-vs-Extreme_Obese |
5.38929999960303E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.988950E-01 |
| Normal_Weight-vs-Obese |
3.992800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.495600E-01 |
| Extreme_Weight-vs-Obese |
2.932300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.373200E-01 |
| Obese-vs-Extreme_Obese |
2.254400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.834030E-02 |
| Normal-vs-Age(41-60Yrs) |
2.66790000091888E-08 |
| Normal-vs-Age(61-80Yrs) |
6.13142869809735E-12 |
| Normal-vs-Age(81-100Yrs) |
1.386080E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.909600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.454600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.384100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.252370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.352000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.255600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.48630063390965E-11 |
| Normal-VS-Type2 PRCC |
3.95400046038219E-10 |
| Normal-VS-KIRP CIMP |
7.760300E-02 |
| Normal-VS-Unclassified PRCC |
3.209500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.748360E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.800200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.340800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.226600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.680400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.716200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49810164273845E-11 |
| Normal-vs-N1 |
3.796700E-03 |
| Normal-vs-N2 |
1.95709999999405E-05 |
| N0-vs-N1 |
2.725200E-01 |
| N0-vs-N2 |
4.569400E-01 |
| N1-vs-N2 |
3.387000E-01 |
|
|
